• EU approves Vertex’ cystic fibrosis combo pharmatimes
    November 05, 2018
    The European Commission has approved Vertex’ Symveki in a combination regimen with Kalydeco to treat certain patients with cystic fibrosis (CF)...
PharmaSources Customer Service